Literature DB >> 20051966

Obesity: Intragastric balloons--a bubble to combat the obesity bubble?

Elisabeth M H Mathus-Vliegen1.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20051966     DOI： 10.1038/nrgastro.2009.214

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  7 in total

Review 1.  Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health.

Authors: 
Journal:  Obes Res       Date:  1998-09

2.  Obesity and the gastric balloon: a comprehensive workshop. Tarpon Springs, Florida, March 19-21, 1987.

Authors:  M Schapiro; S Benjamin; G Blackburn; B Frank; D Heber; R Kozarek; S Randall; W Stern
Journal:  Gastrointest Endosc       Date:  1987-08       Impact factor: 9.427

3.  Mechanisms of action of the intragastric balloon in obesity: effects on hunger and satiety.

Authors:  R Pasquali; L Besteghi; F Casimirri; N Melchionda; G Di Febo; G Zoccoli; L Barbara; U Tassoni
Journal:  Appetite       Date:  1990-08       Impact factor: 3.868

4.  Intragastric balloon for treatment-resistant obesity: safety, tolerance, and efficacy of 1-year balloon treatment followed by a 1-year balloon-free follow-up.

Authors:  Elisabeth M H Mathus-Vliegen; Guido N J Tytgat
Journal:  Gastrointest Endosc       Date:  2005-01       Impact factor: 9.427

5.  Intragastric balloon reduces food intake and body weight in rats.

Authors:  A Geliebter; S Westreich; D Gage; S A Hashim
Journal:  Am J Physiol       Date:  1986-10

6.  Improvement of metabolic syndrome following intragastric balloon: 1 year follow-up analysis.

Authors:  Nicola Crea; Giacomo Pata; Domenico Della Casa; Luigi Minelli; Giovanni Maifredi; Ernesto Di Betta; Francesco Mittempergher
Journal:  Obes Surg       Date:  2009-06-09       Impact factor: 4.129

7.  Intragastric balloon for weight loss: results in 100 individuals followed for at least 2.5 years.

Authors:  Negrin S Dastis; E François; J Deviere; A Hittelet; A Ilah Mehdi; M Barea; J-M Dumonceau
Journal:  Endoscopy       Date:  2009-07-08       Impact factor: 10.093
  7 in total
  5 in total

1.  Morbidly obese are ghrelin and leptin hyporesponders with lesser intragastric balloon treatment efficiency : ghrelin and leptin changes in relation to obesity treatment.

Authors:  Marko Nikolic; Marko Boban; Neven Ljubicic; Vladimir Supanc; Gorana Mirosevic; Borka Pezo Nikolic; Ruzica Krpan; Ljubica Posavec; Vanja Zjacic-Rotkvic; Miroslav Bekavac-Beslin; Petar Gacina
Journal:  Obes Surg       Date:  2011-10       Impact factor: 4.129

2.  Decrease in insulin resistance has a key role in improvement of metabolic profile during intragastric balloon treatment.

Authors:  Gorana Mirošević; Marko Nikolić; Ivan Kruljac; Neven Ljubičić; Miroslav Bekavac-Bešlin; Milan Milošević; Borka Pezo Nikolić; Vladimir Supanc; Ivan Budimir; Milan Vrkljan
Journal:  Endocrine       Date:  2013-10-17       Impact factor: 3.633

3.  Impact of a 6-month treatment with intragastric balloon on body composition and psychopathological profile in obese individuals with metabolic syndrome.

Authors:  Erika P Guedes; Eduardo Madeira; Thiago T Mafort; Miguel Madeira; Rodrigo O Moreira; Laura Maria C Mendonça; Amélio F Godoy-Matos; Agnaldo J Lopes; Maria Lucia F Farias
Journal:  Diabetol Metab Syndr       Date:  2016-12-19       Impact factor: 3.320

4.  Weight loss with or without intragastric balloon causes divergent effects on ghrelin cell expression.

Authors:  Elisabeth Mathus-Vliegen; Anna Spångeus; Susanna Walter; Ann-Charlott Ericson
Journal:  Obes Sci Pract       Date:  2021-01-13

5.  An update on less invasive and endoscopic techniques mimicking the effect of bariatric surgery.

Authors:  Froukje J Verdam; Ruben Schouten; Jan Willem Greve; Ger H Koek; Nicole D Bouvy
Journal:  J Obes       Date:  2012-08-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.